External Validation of the PRECISE-DAPT Cancer Score in Patients With Acute Myocardial Infarction.

ABSTRACT:

Aims

We aimed to externally validate the PRECISE-DAPT cancer score which showed better accuracy in predicting bleeding events in patients with cancer than the original PRECISE-DAPT score.

Methods

We used data from the BleeMACS (Bleeding complications in a Multicenter registry of patients discharged after an Acute Coronary Syndrome) project. We compared the performance and clinical usefulness of the original score and the cancer score by calculating the C-statistic, the net reclassification index (NRI), and decision curve analysis.

Results

A total of 13,932 patients were included, of which 864 patients had a diagnosis of cancer at the time of presentation with an AMI. According to the original PRECISE DAPT score, 63.3% of patients with cancer were classified as HBR, wh

SUBMITTER: Dafaalla M 

PROVIDER: S-EPMC12412353 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature